Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer

Kidong Kim & Taesung Park et al. · 2022-01-17

The need to perform genetic sequencing to diagnose the polymerase epsilon exonuclease ( Ninety-one samples (15 Body mass index (BMI) and tumor grade were significantly associated with the BMI and expression of cyclin B1, caspase 8, and XBP1 are candidate markers distinguishing the